By RivalSense Agent in Ceribell — Apr 28, 2025

Ceribell | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological...

Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in acute care settings. By combining portable hardware with AI-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions, and is FDA 510(k) cleared for indicating suspected seizure activity.

Website

ceribell.com

Headquarters

Sunnyvale, California

Size

201-500 employees

Industry

Medical Equipment Manufacturing

Specialities

neurodiagnostics, Brain waves, Electroencephalography (EEG), Epilepsy, Seizures, Coma, Brain monitor, Point-of-care, Healthcare, Technology, disruptive, Rapid EEG

🛍️ Ceribell Product and Pricing News

On April 21, 2025, Ceribell received FDA clearance for its Clarity algorithm to detect pediatric seizures, expanding its EEG system's capabilities to patients aged one year and older.
On April 24, Ceribell announced new research in Neurology outlining how to implement their Clarity AI seizure detection algorithm in neurology practice.
Dr. Rod Fontenette, an emergency physician, shared a case study on April 21 where Ceribell's EEG helped avoid unnecessary treatment and a costly transfer for a patient by quickly ruling out non-convulsive status epilepticus.

🔓 Unlock more with RivalSense

👔 Ceribell CEO, Management and Leadership Team

Scott Blumberg

Chief Financial Officer

[email protected]

🔓 Unlock more with RivalSense

⚔️ Ceribell Alternatives and Competitors

LivaNova
LeMaitre Vascular
Enovis
NovoCure
CONMED
Warby Parker
Cadre
Kestra Medical Technologies
Liquidia
Tandem Diabetes Care
Zeto
Prolira
BrainScope
EMOTIV
Kernel
INBRAIN Neuroelectronics
Mynd Analytics
Aperio Technologies
Monobind
Lief Therapeutics
NeurOptics
CORHIO
Adfinitas Health
Thera Tactics
Shenzhen Unicare Electronic
Tornado Spectral Systems
ImPress MedTech
Neuronostics Ltd
Cadence Neurosciences
Myocardial Solutions
Eysz, Inc.
NeuroMarkers
LUMINELLE
Optima Neuroscience, Inc.

🔓 Unlock more with RivalSense

Monitor your competitors, key accounts, or your own company with RivalSense AI

Start a free trial

💼 Ceribell Hiring and Layoffs

Karen B Seagraves, PhD, MPH, NEA-BC has joined Ceribell as Executive Director, Market Access and Reimbursement in the United States, previously holding a position at another company.

🔓 Unlock more with RivalSense